Fabtech Technologies P/B Ratio
Fabtech Technologies (FABTECH) P/B ratio is 1.66 (Moderate), book value per share ₹93.33 vs Healthcare average P/B of -0.94 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see Fabtech Technologies share price today.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
FABTECH P/B Ratio — Valuation Insights & Book Value Analysis
Fabtech Technologies price-to-book ratio interpretation, valuation status and historical context — current P/B 1.66 (Moderate). Compare with FABTECH fundamental valuation to assess whether the stock is under or overvalued.
- Current PB is 37.2% below historical average
- Trading at premium to sector average PB of -0.94
Fabtech Technologies P/B Ratio Historical Trend
FABTECH annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Fabtech Technologies 52-week for the annual high/low range and current price position.
FABTECH Historical P/B Ratio — Book Value Per Share & Year-End Price
Fabtech Technologies annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.65 | ₹93.33 | ₹153.55 | ₹420 | Moderate |
| 2025 | 3.64 | ₹54.06 | ₹196.71 | ₹173 | High |
FABTECH vs Healthcare Peers — P/B Ratio Comparison
Fabtech Technologies P/B 1.66 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |